SEOM-GETNE-TTCC Clinical guideline thyroid cancer (2023).

Authors :: Alonso-Gordoa T
Jimenez-Fonseca P
Martinez-Trufero J
Navarro M
Porras I
Rubió-Casadevall J
Arregui Valles M
Basté N
Hernando J
Iglesias Docampo L
Source :: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico [Clin Transl Oncol] 2024 Nov; Vol. 26 (11), pp. 2902-2916. Date of Electronic Publication: 2024 Sep 26.
Publication Year :: 2024
Abstract: Thyroid cancer (TC) represents 3% of global cancer incidence. Recent changes have optimized treatment decisions based on risk assessment, molecular profiling, and imaging assessment, leading the development of targeted agents that have modified the natural history of this disease. This increasing complexity on treatment options requires careful assessment at the different stages of the disease to provide the most suitable approach from diagnosis to long-term follow-up. This guideline aims to offer a comprehensive and practical overview on the current status and last updates of TC management.<br /> (© 2024. The Author(s).)

Subjects :: Humans
Medical Oncology
Practice Guidelines as Topic
Thyroid Neoplasms therapy
Thyroid Neoplasms diagnosis
Thyroid Neoplasms pathology

Language :: English
ISSN :: 1699-3055
Volume :: 26
Issue :: 11
Database :: MEDLINE
Journal :: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Publication Type :: Academic Journal
Accession number :: 39325263
Full Text :: https://doi.org/10.1007/s12094-024-03736-6